The Food and Drug Administration (FDA) has approved a domestically-developed and produced antibody reagent for the COVID-19 coronavirus disease, the first of its kind licensed in Taiwan, an FDA official said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Minister responds to blockade-induced energy apocalypse fears with vow
10/09/2025 03:21 PM - Business
Taiwan shares close up 0.88%
10/09/2025 02:34 PM - Cross-Strait
Taiwanese hiker confirmed dead in China's Qinghai after mass stranding
10/09/2025 02:22 PM - Society
- Society
Taiwan's foreign ministry, Tzu Chi sign MOU on post-disaster relief
10/09/2025 10:24 AM